Northstar Asset Management LLC decreased its holdings in Stryker Co. (NYSE:SYK) by 2.5% in the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 7,225 shares of the medical technology company’s stock after selling 185 shares during the quarter. Northstar Asset Management LLC’s holdings in Stryker were worth $1,485,000 at the end of the most recent reporting period.

Other institutional investors have also modified their holdings of the company. Farmers National Bank acquired a new stake in Stryker in the 1st quarter worth about $25,000. Cable Hill Partners LLC acquired a new stake in Stryker in the 1st quarter worth about $30,000. RPG Investment Advisory LLC raised its stake in Stryker by 160.0% in the 1st quarter. RPG Investment Advisory LLC now owns 156 shares of the medical technology company’s stock worth $31,000 after purchasing an additional 96 shares in the last quarter. Horan Capital Advisors LLC. acquired a new stake in Stryker in the 1st quarter worth about $40,000. Finally, Webster Bank N. A. raised its stake in Stryker by 300.0% in the 2nd quarter. Webster Bank N. A. now owns 200 shares of the medical technology company’s stock worth $41,000 after purchasing an additional 150 shares in the last quarter. Institutional investors and hedge funds own 73.59% of the company’s stock.

Several analysts have weighed in on the stock. Robert W. Baird lifted their price objective on shares of Verisign from $210.00 to $240.00 and gave the stock an “outperform” rating in a research note on Friday. Cantor Fitzgerald boosted their target price on shares of Stryker from $190.00 to $230.00 and gave the company a “neutral” rating in a research report on Friday. Svb Leerink restated an “outperform” rating on shares of Stryker in a research report on Wednesday, July 10th. Canaccord Genuity boosted their target price on shares of Toromont Industries from C$62.00 to C$64.00 and gave the company a “hold” rating in a research report on Friday. Finally, Piper Jaffray Companies cut shares of Superior Energy Services from an “overweight” rating to a “neutral” rating in a research report on Friday. Four research analysts have rated the stock with a hold rating and eighteen have assigned a buy rating to the stock. Stryker presently has a consensus rating of “Buy” and an average target price of $210.41.

In related news, VP Bijoy Sagar sold 2,000 shares of the company’s stock in a transaction that occurred on Monday, May 6th. The shares were sold at an average price of $190.43, for a total transaction of $380,860.00. Following the completion of the transaction, the vice president now directly owns 3,350 shares in the company, valued at approximately $637,940.50. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, insider Timothy J. Scannell sold 4,666 shares of the company’s stock in a transaction that occurred on Tuesday, July 16th. The stock was sold at an average price of $205.88, for a total transaction of $960,636.08. Following the transaction, the insider now owns 155,963 shares of the company’s stock, valued at $32,109,662.44. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 18,698 shares of company stock valued at $3,643,227. 7.20% of the stock is owned by corporate insiders.

SYK stock opened at $214.45 on Friday. The stock’s 50 day moving average is $204.17. The firm has a market cap of $80.01 billion, a PE ratio of 29.34, a price-to-earnings-growth ratio of 2.60 and a beta of 0.87. Stryker Co. has a 1 year low of $144.75 and a 1 year high of $222.59. The company has a debt-to-equity ratio of 0.68, a quick ratio of 1.30 and a current ratio of 2.12.

Stryker (NYSE:SYK) last released its quarterly earnings data on Thursday, July 25th. The medical technology company reported $1.98 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $1.93 by $0.05. The business had revenue of $3.65 billion during the quarter, compared to analysts’ expectations of $3.60 billion. Stryker had a net margin of 24.99% and a return on equity of 26.47%. The firm’s quarterly revenue was up 9.9% compared to the same quarter last year. During the same period in the prior year, the company earned $1.76 EPS. On average, analysts predict that Stryker Co. will post 8.2 EPS for the current fiscal year.

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, July 31st. Investors of record on Friday, June 28th will be given a dividend of $0.52 per share. This represents a $2.08 dividend on an annualized basis and a yield of 0.97%. The ex-dividend date is Thursday, June 27th. Stryker’s dividend payout ratio is 28.45%.

About Stryker

Stryker Corporation operates as a medical technology company. The company operates through three segments: Orthopaedics, MedSurg, and Neurotechnology and Spine. The Orthopaedics segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. The MedSurg segment offers surgical equipment and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, and other medical devices for use in various medical specialties.

Read More: What are the benefits of momentum investing?

Institutional Ownership by Quarter for Stryker (NYSE:SYK)

Receive News & Ratings for Stryker Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stryker and related companies with MarketBeat.com's FREE daily email newsletter.